Related Experiment Video
Updated: Apr 21, 2026
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Transcatheter device closure of patent ductus arteriosus
Mehboob Sultan1, Maad Ullah1, Nadeem Sadiq1
1Department of Paediatric Cardiology, Armed Forces Institute of Cardiology and National Institute of Heart Diseases (AFIC/NIHD), Rawalpindi.
Objective:
To determine the efficacy, safety and immediate complications encountered during percutaneous device closure of patent ductus arteriosus (PDA).
Study Design:
Case series.
Place And Duration Of Study:
Department of Paediatric Cardiology, AFIC/NIHD, Rawalpindi, from January 2005 to December 2010.
Methodology:
Consecutive 500 patients who underwent attempted transcatheter PDA device closure were included in the study. Device type position, success of closure and complications were described as frequency percentage.
Results:
In 491 cases (98.2%), PDA was successfully occluded including 4 cases (0.8%) where devices were dislodged but retrieved and redeployed in Cath laboratory. PDA occluder devices used in 448 cases (91%) while coils (single or multiple) were used in 42 cases (8.5%) and in one case (0.2%) ASD occluder device was used to occlude the PDA. There were 09 (1.8%) unsuccessful cases, 06 (1.2%) were abandoned as ducts were considered unsuitable for device closure, 02 (0.4%) devices dislodged and needed surgical retrieval and one case (0.2%) was abandoned due to faulty equipment. The narrowest PDA diameter ranged from 0.5-14 mm with mean of 4.5±2.4 mm. There was a single (0.2%) mortality.
Conclusion:
Transcatheter occlusion of PDA by coil or occluder device is an effective therapeutic option with high success rate. Complication rate is low in the hands of skilled operators yet paediatric cardiac surgical back-up cover is mandatory.
